Lupin share price

Stocks

Lupin Signs US Licensing Deal for Cancer Biosimilar; Shares End Flat
Byaea2ede5_admin December 4, 2025

December 4, 2025December 4, 2025 Shares of Lupin Ltd ended flat on 4th December, even though the firm said it has signed an exclusive licensing agreement with US-based Valorum Biologics for its biosimilar Armlupeg (pegfilgrastim-unne). Under the agreement, Valorum will handle the commercialisation and distribution…

Read More Lupin Signs US Licensing Deal for Cancer Biosimilar; Shares End Flat
Stocks

Overweight on Lupin, target price Rs 2,600: Axis Securities
Byaea2ede5_admin January 14, 2025

Axis Securities has an overweight call on Lupin with a target price of Rs 2600. The current market price of Lupin is Rs 2160. Lupin, incorporated in 1983, is a Large Cap company with a market cap of Rs 99094.85 crore, operating in the pharmaceuticals sector. Lupin’s key products/revenue segments include Pharmaceuticals, Other Services, Export…

Read More Overweight on Lupin, target price Rs 2,600: Axis Securities